No benefit for post-operative radiotherapy in non-small-cell lung cancer

Lugano, Switzerland, 20 September 2020 – Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020. These results give the oncology community a long-awaited answer. (1) PORT in completely…

Details

On Racism and British Fashion

“I’ve always considered myself an outsider,” Osman Yousefzada said last week, sitting on a park bench near his home in North London. “Often, I’ve also been made to feel like an outsider, working in and around institutions and industries like fashion that are rooted in white codes and elitism.” At 43, he is an established…

Details